Microbial Pulse Diagnostics is developing an innovative NIST technology for the rapid measurement of antimicrobial susceptibility.
Microbial Pulse Diagnostics is developing and deploying an innovative NIST technology for the rapid measurement of antimicrobial susceptibility. This technology “takes the pulse” of bacterial cells, sensing changes in their metabolism, motility, and growth after exposure to an effective antibiotic.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 24, 2019 | Grant | $112K | 1 |
|
— | Detail |
Jan 29, 2019 | Grant | $225K | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
|
Yes | Grant |
![]() |
Yes | Grant |